Orthopediatrics Corp (KIDS)

Currency in USD
19.22
-1.16(-5.69%)
Closed·
19.220.00(0.00%)
·
Advertisement
KIDS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.0620.36
52 wk Range
14.4223.70
Key Statistics
Prev. Close
20.38
Open
19.9
Day's Range
19.06-20.36
52 wk Range
14.42-23.7
Volume
128.15K
Average Volume (3m)
161.25K
1-Year Change
-12.6988%
Book Value / Share
13.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KIDS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.00
Upside
+30.07%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Orthopediatrics Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 25.00
(+30.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Hold20.00+4.06%17.00Maintain16/07/2026
TD Cowen
Buy23.00+19.67%-Maintain15/06/2026
Truist Securities
Hold17.00-11.55%20.00Maintain01/05/2026
Truist Securities
Hold20.00+4.06%19.00Maintain02/03/2026
Stifel
Buy22.00+14.46%20.00Maintain27/02/2026

Orthopediatrics Corp SWOT Analysis


Pediatric Orthopedics
OrthoPediatrics Corp. dominates the niche pediatric orthopedic market, leveraging specialized focus to drive impressive growth and expand market presence
Financial Momentum
Explore OrthoPediatrics' robust financial performance, with Q3 2024 revenue surpassing estimates and full-year guidance raised to $202-$204 million
Strategic Expansion
Delve into the company's ambitious clinic network expansion plans, aiming to open 18 new markets by 2027 and strengthen its market position
Future Projections
Analysts project revenue to reach $242-$244 million by 2025, with improving profitability and a target price of $50 set by JMP Securities
Read full SWOT analysis

Orthopediatrics Corp Earnings Call Summary for Q1/2026

  • OrthoPediatrics Q1 2026 revenue hit $59.4M (up 13% YoY), beating estimates of $58.34M; EPS of -$0.45 exceeded forecast of -$0.48.
  • Adjusted EBITDA improved to $2.2M from -$0.4M loss in Q1 2025; gross margin held steady at 73% amid strong cost management.
  • Stock surged 6.76% to $15.63 in after-hours trading following the earnings beat, reflecting investor confidence in growth trajectory.
  • Company secured $20M financing facility to fund strategic initiatives without shareholder dilution; expects growth from 3P Platform launch.
  • Management projects continued revenue expansion through new scoliosis systems and international growth, particularly in Europe post-EU MDR approval.
Last Updated: 05/05/2026, 17:46
Read Full Transcript

Earnings

Latest Release
30/04/2026
EPS / Forecast
-0.45 / -0.48
Revenue / Forecast
59.4M / 58.34M
EPS Revisions
Last 90 days

Compare KIDS to Peers and Sector

Metrics to compare
KIDS
Peers
Sector
Relationship
P/E Ratio
−12.4x6.2x−0.4x
PEG Ratio
−3.00−0.010.00
Price/Book
1.5x3.6x2.6x
Price / LTM Sales
2.0x3.1x3.0x
Upside (Analyst Target)
24.9%90.8%53.5%
Fair Value Upside
Unlock41.0%9.0%Unlock

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.91M23.00%113.49M
Other Institutional Investors
18.49M72.00%355.37M
Public Companies & Retail Investors
1.28M5.00%24.68M
Total
25.68M100.00%493.54M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Squadron Capital, LLC26.87%6,901,764132,617
Brown Advisory Incorporated5.91%1,518,01829,169

People Also Watch

46.88
TRMK
-1.64%
62.68
LKFN
-1.46%
36.73
IVT
+0.05%
3.33
MLCI
-1.48%
38.29
CENTA
-1.82%

FAQ

What Is the Orthopediatrics (NASDAQ: KIDS) Share Price Today?

The Orthopediatrics stock price today is 19.22 USD.

What Stock Exchange Does Orthopediatrics (KIDS) Trade On?

Orthopediatrics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Orthopediatrics?

The stock symbol (also called a 'ticker') for Orthopediatrics is "KIDS."

What Is the Current Orthopediatrics Market Capitalisation?

As of today, Orthopediatrics (NASDAQ: KIDS) market cap is 493.54M USD.

What Is Orthopediatrics's (KIDS) Earnings Per Share (TTM)?

The Orthopediatrics EPS is currently -1.68 (Trailing Twelve Months).

When Is the Next Orthopediatrics Earnings Date?

Orthopediatrics's next earnings report will be released on 05/08/2026.

Is KIDS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Orthopediatrics moving averages and other technical indicators, the daily buy/sell signal for KIDS stock is Neutral.

How Many Times Has Orthopediatrics Stock Split?

Orthopediatrics has split 0 times. (See the KIDS stock split history page for full effective split date and price information.)

How Many Employees Does Orthopediatrics Have?

Orthopediatrics has 602 employees, based on their latest Companies House report.

What is the current trading status of Orthopediatrics (NASDAQ: KIDS)?

As of 19/07/2026, Orthopediatrics (KIDS) is trading at a share price of 19.22 USD, with a previous close of 20.38 USD. The stock has fluctuated within a day range of 19.06 USD to 20.36 USD, while its 52-week range spans from 14.42 USD to 23.70 USD.

What Is Orthopediatrics (KIDS) Price Target According to Analysts?

The average 12-month price target for Orthopediatrics is 25.00 USD, with a high estimate of 34 USD and a low estimate of 20 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +30.07% Upside potential.

What Is the KIDS Premarket Price?

KIDS's last pre-market stock price is 20.05 USD. The pre-market share volume is 510.00, and the stock has decreased by -0.33, or -1.62%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.